Skip to main content
. 2022 Feb 23;9:787975. doi: 10.3389/fcvm.2022.787975

Table 1.

Published data on the incidence of post-transplant lymphoproliferative disorder in cardiac transplant recipients.

References Number of HT recipients Number of PTLD cases PTLD incidence Follow-up time
Couetil et al. (31) 275 2 0.7% NA
Grattan et al. (32) 310 11 3.5% NA
Swinnen et al. (33) 154 10 6.5% NA
Armitage et al. (34) 439 15 3.4% NA
Rinde-Hoffman et al. (35) 92 5 5.5% NA
Chen et al. (36) 424 19 4.5% 0.5 years (median)
Mihalov et al. (37) 307 21 6.8% NA
Hsu et al. (38) 156 4 2.6% 4.3 years (mean)
Yagdi et al. (15) 835 30 3.6% 9.6 years (median)
Crespo-Leiro et al. (14) 3,393 62 1.8% 5.2 years (median)
Fröhlich et al. (5) 255 18 7.0% 12.6 years (median).
Higgins et al. (39) 6,211 88 1.4% 5.5 years (median)
Rivinius et al. (40) 381 11 2.9% 9.7 years (mean)
Youn et al. (41) NA
2000–2005 8,555 83 1.0%
2006–2011 9,032 75 0.9%
Asleh et al. (42) 523 24 4.6% (0.6 events per 100 person-years) 9 years (median)

HT, heart transplant; PTLD, post-transplant lymphoproliferative disorder.